C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma

C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma

Cutaneous T cell lymphomas (CTCLs) represent a heterogeneous group of T cell lymphomas that primarily affect the skin. The most frequent forms of CTCL are mycosis fungoides and Sézary syndrome. Both are characterized by frequent recurrence, developing chronic conditions and high mortality with a lac...

Full description

Bibliographic Details
Main Authors: Raphael Wilhelm, Timon Eckes, Gergely Imre, Stefan Kippenberger, Markus Meissner, Dominique Thomas, Sandra Trautmann, Jean-Philippe Merlio, Edith Chevret, Roland Kaufmann, Josef Pfeilschifter, Alexander Koch, Manuel Jäger
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
C6 ceramide
short-chain ceramide
cutaneous T cell lymphoma
skin
Online Access:https://www.mdpi.com/2072-6694/13/2/270

Internet

https://www.mdpi.com/2072-6694/13/2/270

Similar Items